Plain-English translation of NCT07409077 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Glaucoma damages the optic nerve and can cause permanent vision loss, but current treatments mainly focus on controlling eye pressure rather than helping people use their remaining vision better. This trial is testing a rehabilitation technique called biofeedback training, which uses visual and auditory feedback to teach your eyes to use healthier parts of your retina for seeing. The goal is to help you see better and improve your daily life.
Once glaucoma has damaged your vision, there aren't many options to rehabilitate or improve how well you can see. This trial exists to find out if this training approach can help people with glaucoma make better use of the vision they have left.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly assigned to either receive the training right away or to a control group that waits. Those receiving training will attend five weekly in-office sessions, each lasting about 20 minutes, where you'll receive visual and auditory feedback to guide your eye movements. All participants will complete vision assessments at the beginning and at follow-up visits to measure changes in your fixation stability, vision clarity, reading speed, and overall quality of life.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada